South Korean Pharmas Clamber For Partnerships To Survive Rapidly Changing Environment
This article was originally published in PharmAsia News
SEOUL - South Korea's local pharmas are clambering to tie the knot with multinationals and among themselves in what appears to be a "marriage of necessity" in a desperate attempt to survive a government crackdown on rebates, on which locals have long depended
You may also be interested in...
Fifteen Korean Drug Firms Granted Innovative Status Charged With Unfair Trade Practices
Old habits seem to die hard as 15 Korean pharma companies among 43 granted tax breaks and financial incentives to compete at home and abroad are charged with unfair trade practices, including making rebate payments to secure orders.
Korean Pharma Earnings Roundup: Companies Struggled In First Quarter Because of April Price Cuts And Tightened Regulatory Grip On Rebates
As widely expected, top Korean companies were badly hit during the first quarter by April price cuts and a continuing government crackdown on rebates.
Is M&A The Survival Strategy For Korean Companies? KPMA President Lee Kyeong-Ho Thinks So
Lee Kyeong-Ho, president of the Korea Pharmaceutical Manufacturers Association, expects that local Korean companies will have to pursue M&A to survive a harsh business environment.